Entrez Id: |
3767 |
Gene Symbol: |
KCNJ11 |
KCNJ11
|
potassium inwardly rectifying channel subfamily J member 11
|
0.529 |
0.615 |
1.1E-02 |
Impaired glucose tolerance
|
phenotype |
0.060 |
None
|
1.000 |
6 |
2 |
2004 |
2010 |
Entrez Id: |
3767 |
Gene Symbol: |
KCNJ11 |
KCNJ11
|
potassium inwardly rectifying channel subfamily J member 11
|
0.529 |
0.615 |
1.1E-02 |
Developmental delay (disorder)
|
phenotype |
0.060 |
None
|
1.000 |
6 |
7 |
2005 |
2011 |
Entrez Id: |
3767 |
Gene Symbol: |
KCNJ11 |
KCNJ11
|
potassium inwardly rectifying channel subfamily J member 11
|
0.529 |
0.615 |
1.1E-02 |
K ATP Permanent Neonatal Diabetes
|
disease |
0.050 |
None
|
1.000 |
5 |
1 |
2005 |
2010 |
Entrez Id: |
3767 |
Gene Symbol: |
KCNJ11 |
KCNJ11
|
potassium inwardly rectifying channel subfamily J member 11
|
0.529 |
0.615 |
1.1E-02 |
Diabetic Ketoacidosis
|
disease |
0.040 |
None
|
1.000 |
3 |
0 |
2005 |
2018 |
Entrez Id: |
3767 |
Gene Symbol: |
KCNJ11 |
KCNJ11
|
potassium inwardly rectifying channel subfamily J member 11
|
0.529 |
0.615 |
1.1E-02 |
Essential Hypertension
|
disease |
0.030 |
None
|
1.000 |
3 |
2 |
2011 |
2019 |
Entrez Id: |
3767 |
Gene Symbol: |
KCNJ11 |
KCNJ11
|
potassium inwardly rectifying channel subfamily J member 11
|
0.529 |
0.615 |
1.1E-02 |
Polycystic Ovary Syndrome
|
disease |
0.030 |
None
|
0.333 |
3 |
1 |
2007 |
2013 |
Entrez Id: |
3767 |
Gene Symbol: |
KCNJ11 |
KCNJ11
|
potassium inwardly rectifying channel subfamily J member 11
|
0.529 |
0.615 |
1.1E-02 |
HIV-1 infection
|
disease |
0.020 |
None
|
1.000 |
2 |
0 |
2003 |
2013 |
Entrez Id: |
3767 |
Gene Symbol: |
KCNJ11 |
KCNJ11
|
potassium inwardly rectifying channel subfamily J member 11
|
0.529 |
0.615 |
1.1E-02 |
Harlequin Fetus
|
disease |
0.020 |
None
|
1.000 |
2 |
0 |
2006 |
2010 |
Entrez Id: |
3767 |
Gene Symbol: |
KCNJ11 |
KCNJ11
|
potassium inwardly rectifying channel subfamily J member 11
|
0.529 |
0.615 |
1.1E-02 |
Primary malignant neoplasm
|
group |
0.020 |
None
|
1.000 |
2 |
0 |
2012 |
2017 |
Entrez Id: |
3767 |
Gene Symbol: |
KCNJ11 |
KCNJ11
|
potassium inwardly rectifying channel subfamily J member 11
|
0.529 |
0.615 |
1.1E-02 |
Malignant neoplasm of pancreas
|
disease |
0.020 |
None
|
1.000 |
2 |
1 |
2014 |
2017 |
Entrez Id: |
3767 |
Gene Symbol: |
KCNJ11 |
KCNJ11
|
potassium inwardly rectifying channel subfamily J member 11
|
0.529 |
0.615 |
1.1E-02 |
Malignant neoplasm of urinary bladder
|
disease |
0.020 |
None
|
1.000 |
2 |
0 |
2017 |
2019 |
Entrez Id: |
3767 |
Gene Symbol: |
KCNJ11 |
KCNJ11
|
potassium inwardly rectifying channel subfamily J member 11
|
0.529 |
0.615 |
1.1E-02 |
Carcinoma of bladder
|
disease |
0.020 |
None
|
1.000 |
2 |
0 |
2017 |
2019 |
Entrez Id: |
3767 |
Gene Symbol: |
KCNJ11 |
KCNJ11
|
potassium inwardly rectifying channel subfamily J member 11
|
0.529 |
0.615 |
1.1E-02 |
Metabolic Syndrome X
|
disease |
0.020 |
None
|
1.000 |
2 |
1 |
2017 |
2017 |
Entrez Id: |
3767 |
Gene Symbol: |
KCNJ11 |
KCNJ11
|
potassium inwardly rectifying channel subfamily J member 11
|
0.529 |
0.615 |
1.1E-02 |
Malignant Neoplasms
|
group |
0.020 |
None
|
1.000 |
2 |
0 |
2012 |
2017 |
Entrez Id: |
3767 |
Gene Symbol: |
KCNJ11 |
KCNJ11
|
potassium inwardly rectifying channel subfamily J member 11
|
0.529 |
0.615 |
1.1E-02 |
Bladder Neoplasm
|
disease |
0.020 |
None
|
1.000 |
2 |
0 |
2017 |
2019 |
Entrez Id: |
3767 |
Gene Symbol: |
KCNJ11 |
KCNJ11
|
potassium inwardly rectifying channel subfamily J member 11
|
0.529 |
0.615 |
1.1E-02 |
Diabetic Retinopathy
|
disease |
0.020 |
None
|
1.000 |
2 |
1 |
2015 |
2018 |
Entrez Id: |
3767 |
Gene Symbol: |
KCNJ11 |
KCNJ11
|
potassium inwardly rectifying channel subfamily J member 11
|
0.529 |
0.615 |
1.1E-02 |
[D]Sleep disturbances (& [hypersomnia] or [insomnia])
|
phenotype |
0.010 |
None
|
1.000 |
1 |
0 |
2017 |
2017 |
Entrez Id: |
3767 |
Gene Symbol: |
KCNJ11 |
KCNJ11
|
potassium inwardly rectifying channel subfamily J member 11
|
0.529 |
0.615 |
1.1E-02 |
Hypoglycaemic episode
|
disease |
0.010 |
None
|
1.000 |
1 |
1 |
2017 |
2017 |
Entrez Id: |
3767 |
Gene Symbol: |
KCNJ11 |
KCNJ11
|
potassium inwardly rectifying channel subfamily J member 11
|
0.529 |
0.615 |
1.1E-02 |
Sleep Disorders
|
group |
0.010 |
None
|
1.000 |
1 |
0 |
2017 |
2017 |
Entrez Id: |
3767 |
Gene Symbol: |
KCNJ11 |
KCNJ11
|
potassium inwardly rectifying channel subfamily J member 11
|
0.529 |
0.615 |
1.1E-02 |
Amyotrophic Lateral Sclerosis
|
disease |
0.010 |
None
|
1.000 |
1 |
0 |
2018 |
2018 |
Entrez Id: |
3767 |
Gene Symbol: |
KCNJ11 |
KCNJ11
|
potassium inwardly rectifying channel subfamily J member 11
|
0.529 |
0.615 |
1.1E-02 |
Arteriosclerosis
|
disease |
0.010 |
None
|
1.000 |
1 |
0 |
2018 |
2018 |
Entrez Id: |
3767 |
Gene Symbol: |
KCNJ11 |
KCNJ11
|
potassium inwardly rectifying channel subfamily J member 11
|
0.529 |
0.615 |
1.1E-02 |
Atherosclerosis
|
disease |
0.010 |
None
|
1.000 |
1 |
0 |
2018 |
2018 |
Entrez Id: |
3767 |
Gene Symbol: |
KCNJ11 |
KCNJ11
|
potassium inwardly rectifying channel subfamily J member 11
|
0.529 |
0.615 |
1.1E-02 |
Attention deficit hyperactivity disorder
|
disease |
0.010 |
None
|
1.000 |
1 |
0 |
2017 |
2017 |
Entrez Id: |
3767 |
Gene Symbol: |
KCNJ11 |
KCNJ11
|
potassium inwardly rectifying channel subfamily J member 11
|
0.529 |
0.615 |
1.1E-02 |
Pre-renal acute kidney injury
|
disease |
0.010 |
None
|
1.000 |
1 |
0 |
2014 |
2014 |
Entrez Id: |
3767 |
Gene Symbol: |
KCNJ11 |
KCNJ11
|
potassium inwardly rectifying channel subfamily J member 11
|
0.529 |
0.615 |
1.1E-02 |
Post transplant diabetes mellitus
|
disease |
0.010 |
None
|
< 0.001 |
1 |
0 |
2017 |
2017 |